Announcements

NEHI has released a report that proposes five principles of communication for shaping exchanges of information among patient groups and U.S. health care payers to enhance and promote trust in payer decision-making on coverage of novel therapies.

NEHI has partnered with Eli Lilly & Company and Avalere Health to release a new report today on advancing health and health care equity in the United States.

Watch NEHI's Policy and Research Director, Tom Hubbard, speak at the Rhode Island Business Group on Health's webinar on chronic disease.

NEHI received a funding award from the Eugene Washington Patient-Centered Outcomes Research Institute (PCORI) Engagement Awards Program.

NEHI announced today that the Patient Centered Outcomes Research Institute (PCORI) has committed $100,000 funding for a NEHI project that will bring patient and payer leaders together to identify principles of good, evidence-based, two-way communication regarding novel therapies

FOR IMMEDIATE RELEASE

NEHI (Network for Excellence in Health Innovation) – a national nonprofit, nonpartisan organization committed to advancing innovations that improve health, enhance the quality of health care, and achieve greater value for the money spent – announced today that its board of directors has unanimously selected Wendy Warring to serve as the organization’s next President and CEO.

NEHI (The Network for Excellence in Health Innovation) released a white paper today recommending that Massachusetts health care payers, providers, and the state's biopharma industry come together in collaboration to address the unique payment and insurance coverage challenges raised by very highly innovative, "next generation" therapies.

Health Care Without Walls: A Roadmap for Reinventing U.S. Health Care embraces this vision of a more “distributed” health care system extending outside of traditional institutional settings – and that would be more convenient, accessible, and arguably less costly than what the United States has now.

NEHI has submitted the following comments in response to the HHS Request for Information: “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.”